Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 4
1946 16
1947 22
1948 12
1949 3
1950 22
1951 41
1952 27
1953 27
1954 37
1955 67
1956 166
1957 300
1958 331
1959 341
1960 508
1961 633
1962 728
1963 922
1964 1119
1965 892
1966 699
1967 640
1968 775
1969 769
1970 775
1971 920
1972 868
1973 858
1974 928
1975 952
1976 946
1977 1102
1978 1361
1979 1514
1980 1658
1981 1757
1982 1992
1983 1817
1984 1724
1985 1754
1986 1773
1987 1629
1988 1713
1989 2125
1990 2165
1991 2151
1992 2140
1993 2083
1994 2314
1995 2793
1996 3560
1997 3623
1998 4077
1999 4508
2000 4968
2001 5456
2002 6163
2003 6822
2004 7115
2005 7887
2006 8789
2007 10083
2008 10598
2009 11448
2010 13287
2011 14466
2012 15270
2013 15738
2014 17112
2015 18097
2016 17909
2017 16760
2018 15136
2019 7730
2020 255
Text availability
Article attribute
Article type
Publication date

Search Results

272,939 results
Results by year
Filters applied: . Clear all
Page 1
RET fusions in solid tumors
Li AY, et al. Cancer Treat Rev 2019 - Review. PMID 31715421
Gut microbiota and cancer: How gut microbiota modulates activity, efficacy and toxicity of antitumoral therapy
Gori S, et al. Crit Rev Oncol Hematol 2019 - Review. PMID 31634731
Also, it modulates the activity, efficacy and toxicity of several chemotherapy agents, such as gemcitabine, cyclophosphamide, irinotecan, cisplatin and 5-Fluorouracil, and target therapy, such as tyrosine kinase inhibitors. ...
Also, it modulates the activity, efficacy and toxicity of several chemotherapy agents, such as gemcitabine, cyclophosphamide, irinote …
A selective BCL-XL PROTAC degrader achieves safe and potent antitumor activity
Khan S, et al. Nat Med 2019. PMID 31792461 Free PMC article.
However, the on-target and dose-limiting thrombocytopenia limits the use of BCL-X(L) inhibitors, such as ABT263, as safe and effective anticancer agents. ...In vivo, DT2216 effectively inhibits the growth of several xenograft tumors as a single agent or in combination with other chemotherapeutic agents, without causing appreciable thrombocytopenia. ...
However, the on-target and dose-limiting thrombocytopenia limits the use of BCL-X(L) inhibitors, such as ABT263, as safe and effective antic …
272,939 results
Jump to page
Feedback